Recording of Non-Operating Expenses (Consolidated and Non-Consolidated)
WIZE Co., Ltd. (reporting company)
The 39th Series Stock Acquisition Rights issued through a third-party allotment to EVO FUND, and crypto assets purchased by the Company
Expenses associated with the issuance of the 39th Series Stock Acquisition Rights, and a valuation loss on the balance of crypto assets purchased by the Company held at the end of the second-quarter consolidated accounting period
¥9 million in stock acquisition rights issuance costs (consolidated) and ¥10 million (non-consolidated), and a ¥33 million valuation loss on crypto assets (consolidated and non-consolidated). All of these were recorded as non-operating expenses.
Cumulative second quarter of the fiscal year ending December 2026
| Item | Details |
|---|---|
| Event name | Recording of Non-Operating Expenses (Consolidated and Non-Consolidated) |
| Subject Entity | WIZE Co., Ltd. (reporting company) |
| Target Locations / Products | The 39th Series Stock Acquisition Rights issued through a third-party allotment to EVO FUND, and crypto assets purchased by the Company |
| Cause | Expenses associated with the issuance of the 39th Series Stock Acquisition Rights, and a valuation loss on the balance of crypto assets purchased by the Company held at the end of the second-quarter consolidated accounting period |
| Amount of Impact on Business Performance | ¥9 million in stock acquisition rights issuance costs (consolidated) and ¥10 million (non-consolidated), and a ¥33 million valuation loss on crypto assets (consolidated and non-consolidated). All of these were recorded as non-operating expenses. |
| Accounting period in which recognized | Cumulative second quarter of the fiscal year ending December 2026 |
Items this document does not state (19)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company recorded expenses associated with the issuance of the 39th Series Stock Acquisition Rights allocated to EVO FUND, and a valuation loss on the balance of crypto assets purchased by the Company held at the end of the second-quarter consolidated accounting period.